abstract |
PTH receptor agonists where the symptoms associated with the growth of bone metastases or primary bone cancers such as bone loss, fractures, and pain may be PTH, PTH fragments, or analogs thereof, or parathyroid hormone related proteins, fragments or analogs thereof Can be improved by administering an effective amount. |